Similares a Understanding the FDA's Plausible Mechanism Framework
20 vecinos (text_768) · 276 views · National Organization for Rare Disorders (NORD) · Estados Unidos
| ★ | Understanding the FDA's Plausible Mechanism Framework | National Organization for Rare Disorders (NORD) @raredisorders | 276 | Estados Unidos | |
| 7 | Dr. Vinay Prasad Keynote Address - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 814 | Estados Unidos | 87 |
| 14 | Rewriting the Rules: Scaling Innovation for Rare Diseases | Global Conference 2026 | Milken Institute @milkeninstitute | 497 | Estados Unidos | 87 |
| 10 | GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals | U.S. Food and Drug Administration @us_fda | 409 | Estados Unidos | 87 |
| 12 | Countdown to Rare Disease Day 2026! | National Organization for Rare Disorders (NORD) @raredisorders | 277 | Estados Unidos | 87 |
| 4 | NORD® Rare Disease Scientific Symposium 2025 | National Organization for Rare Disorders (NORD) @raredisorders | 173 | Estados Unidos | 88 |
| 19 | GDF2026 - Overview of the FDA Product-Specific Guidance (PSG) Program | U.S. Food and Drug Administration @us_fda | 166 | Estados Unidos | 86 |
| 5 | Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 153 | Estados Unidos | 87 |
| 16 | Stay Covered: Open Enrollment Essentials for Rare Disease Families | National Organization for Rare Disorders (NORD) @raredisorders | 152 | Estados Unidos | 86 |
| 2 | Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 129 | Estados Unidos | 90 |
| 3 | Registries and Real World Data as Development Platforms - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 99 | Estados Unidos | 89 |
| 17 | Keynote Address: Annica Wayman, PhD, NIH – NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 93 | Estados Unidos | 86 |
| 1 | Learn How to Support Our Rare Disease Citizen Petition to the FDA | National Organization for Rare Disorders (NORD) @raredisorders | 76 | Estados Unidos | 91 |
| 18 | NORD® Rare Disease Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 71 | Estados Unidos | 86 |
| 6 | What’s Next in Rare Disease Data Collection and Clinical Use - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 70 | Estados Unidos | 87 |
| 8 | NORD® Rare Disease Scientific Symposium Promo Video | National Organization for Rare Disorders (NORD) @raredisorders | 64 | Estados Unidos | 87 |
| 20 | GDF2026 - Product-Specific Guidances (PSGs) in Action – Key Lessons and Common Questions | U.S. Food and Drug Administration @us_fda | 58 | Estados Unidos | 86 |
| 9 | GDF2026 - Decoding PSGs for Complex Non-Oral Generics | U.S. Food and Drug Administration @us_fda | 49 | Estados Unidos | 87 |
| 13 | GDF2026 - Proactive Strategies to Avoid Major Filing Deficiencies and Other Filing Stumbling Blocks | U.S. Food and Drug Administration @us_fda | 25 | Estados Unidos | 87 |
| 15 | Whitepaper: Accelerating access: Expedited and harmonised pathways for innovative therapies | ICON Plc @iconplc | 19 | Irlanda | 86 |
| 11 | Fair For Rare: Call for a National Rare Disease Framework | Rare Voices Australia @rarevoicesaustralia2025 | 1 | Australia | 87 |




















